Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gerloff

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|July 25, 2003
Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian populationElena A Gaikovitch, Ingolf Cascorbi, Przemyslaw M Mrozikiewicz, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasisAndreas Geier, Christoph G Dietrich, Sebastian Voigt, et al.
Biochimica Et Biophysica Acta|January 1, 2003
Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the ratAndreas Geier, Christoph G Dietrich, Thomas Gerloff, et al.
Drug Metabolism Reviews|November 24, 2004
Pharmacogenetics-based new therapeutic conceptsIvar Roots, Thomas Gerloff, Christian Meisel, et al.
Journal of Hepatology|July 20, 2002
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachlorideAndreas Geier, Suk Kyum Kim, Thomas Gerloff, et al.
European Journal of Clinical Pharmacology|December 6, 2006
Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokersElena Osswald, Andreas Johne, Gabriele Laschinski, et al.
Clinical Pharmacology and Therapeutics|November 12, 2002
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 geneAndreas Johne, Karla Köpke, Thomas Gerloff, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|July 25, 2003
Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian populationElena A Gaikovitch, Ingolf Cascorbi, Przemyslaw M Mrozikiewicz, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasisAndreas Geier, Christoph G Dietrich, Sebastian Voigt, et al.
Biochimica Et Biophysica Acta|January 1, 2003
Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the ratAndreas Geier, Christoph G Dietrich, Thomas Gerloff, et al.
Drug Metabolism Reviews|November 24, 2004
Pharmacogenetics-based new therapeutic conceptsIvar Roots, Thomas Gerloff, Christian Meisel, et al.
Journal of Hepatology|July 20, 2002
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachlorideAndreas Geier, Suk Kyum Kim, Thomas Gerloff, et al.
European Journal of Clinical Pharmacology|December 6, 2006
Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokersElena Osswald, Andreas Johne, Gabriele Laschinski, et al.
Clinical Pharmacology and Therapeutics|November 12, 2002
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 geneAndreas Johne, Karla Köpke, Thomas Gerloff, et al.
Pageof 2